Cosmos Operating Cycle from 2010 to 2024

COSM Stock  USD 0.80  0.01  1.23%   
Cosmos Health Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 118.02. During the period from 2010 to 2024, Cosmos Health Operating Cycle quarterly data regression pattern had sample variance of  3,507 and median of  202.65. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
170.77078433
Current Value
118.02
Quarterly Volatility
59.22404084
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 26.8 M or Other Operating Expenses of 69.8 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 3.44 or PTB Ratio of 0.49. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
  
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.

Latest Cosmos Health's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Cosmos Health over the last few years. It is Cosmos Health's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Cosmos Operating Cycle Regression Statistics

Arithmetic Mean166.54
Geometric Mean153.30
Coefficient Of Variation35.56
Mean Deviation51.18
Median202.65
Standard Deviation59.22
Sample Variance3,507
Range162
R-Value(0.30)
Mean Square Error3,429
R-Squared0.09
Significance0.27
Slope(4.02)
Total Sum of Squares49,105

Cosmos Operating Cycle History

2024 118.02
2023 170.77
2022 193.4
2021 219.57
2020 202.65
2019 120.47
2018 82.37

About Cosmos Health Financial Statements

Cosmos Health investors utilize fundamental indicators, such as Operating Cycle, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 170.77  118.02 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.45)
Revenue Per Share
3.733
Quarterly Revenue Growth
0.068
Return On Assets
(0.20)
Return On Equity
(0.57)
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.